Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane

Ginsenoside-Rb2 derived from ginseng inhibited invasiveness to the basement membrane of endometrial cancer cell lines Ishikawa. HHUA and HEC-1-A cells. These cells dominantly expressed matrix metalloproteinase (MMP)-2 (gelatinase A) among MMPs by zymography. Ginsenoside-Rb2 suppressed the expression and activity of MMP-2, but did not alter the expression of tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in the cells. Therefore, ginsenoside-Rb2 might inhibit invasiveness to the basement membrane via MMP-2 suppression in some endometrial cancers, and can be used as a medicine for inhibition of secondary spreading of uterine endometrial cancers.

Ginsenoside-Rb2; Ginseng; Matrix metalloproteinase; Invasion; Endometrial cancer

[1] Zhu J. H., Takeshita T., Kitagawa I.,M orimoto K.: "Suppression of the formation of sister chromatid exchanges by low concentrations of ginsenoside Rh2 in human blood lymphocytes". Cancer Res., 1995, 55, 1221.

[2] Matsunaga H., Katano M., Yamamoto H., Mori M., Takata K.: "Studies on the panaxytriol of Panax ginseng C. A. Meyer. Isolation, determination and antitumor activity". Chem. Pharm. Bull., 1999, 37, 1279.

[3] Yun T. K., Yun Y. S., Han I. W.: "Anticarcinogenic effect of longterm oral administration of red ginseng on newborn mice exposed to various chemical carcinogens". Cancer Detect. Prn,.,1983, 6, 515.

[4] Sato K., Mochizuki M., Saiki., Yoo Y. C., Samukawa K., Azuma I.: "Inhibition of tumor angiogenesis and metastasis by a saponin of Pan ax ginseng, ginsenoside Rb2". Biol. Pharm. Bull., 1994, 17, 635.

[5] Mochizuki M., Yoo Y. C., Matsuzawa K., Sato K., Saiki I., Tonooka S. et al.: "Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng". Biol. Pharm. Bull., 1995, 18, 1197.

[6] Nishida M., Kasahara K., Kaneko M.. Iwasaki H.: "Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors". Acta Obstet. Gynecol. Jpn., 1985, 37, 1103.

[7] Ishiwata I., lshiwata C.: "Effect of estradiol-17 Band progesterone on cell proliferation and differentiation of the human endometrial carcinoma cell line (HHUA) in vitro". Asia-Oceania J. Obstet. Gynaecol., 1984, 10, 531.

[8] Fujimoto J., Hori M., Ichigo S., Morishita S., Tamaya T.: "Estrogen activates migration potential of endometrial cancer cells through basement membrane". Tumor Biol.,1996,17, 48.

[9] Kleinman H. K., McGarvey M. L., Hassell J. R., Star V. L., Cannon F. 8.,L aurie G. E.: "Basement membrane complexes with biological activity". Biochem., 1986, 25, 312.

[10] Davies 8., Wavman J., Wasan H., Abel P., Williams G., Krausz T et al.: "Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion". Cancer Res., 1993, 53, 5365.

[11] Bradford M.: "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding". Anal. Biochem.,1976, 72, 248.

[12] Tamakoshi K., Kikkawa F., Nawa A., Ishikawa H., Mizuno K., Tamakoshi A. et al.: "Characterization of extracellular matrixdegrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form". Cancer, 1995, 76, 2565.

[13] Ueda M., Fujii H., Yoshizawa K.,A be F.,U eki M.: "Effects of sex steroids and growth factors on migration and invasion of endometrial carcinoma SNG-M cells in vitro". Jpn. J. Cancer Res., 1996, 87, 524.

[14] Inoue Y., Abe K., Obata K., Yoshioka T., Ohmura G., Doh K. et al.: "Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type IV-collagen in endometrial carcinoma". J. Obstet. Gynecol. Res., 1997, 23, 139.

[15] Stetler-Stevenson W. G., Aznavoorian S., Liotta L. A.: "Tumor cell interactions with the extracellular matrix during invasion and metastasis". Annu. Rev. Cell. Biol., 1993, 9, 541.

[16] Yamamoto M., Mohanam S., Sawaya R., Fuller G. N., Seiki M., Sato H. et al.: "Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro". Cancer Res., 1996, 56, 384.

[17] Emonard H. P., Remacle A. G., Noel A. C., Grimaud J. A., StetlerStevenson W. G., Foidart J. M.:'Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase". Cancer Res., 1992, 52, 5845.

[18] Polette M., Nawrocki B., Grilles C., Sato H., Seiki M.,Tournier J M., Birembaut T.: "MT-MMP expression and localization in human lung and breast cancers". Virchows Arch., 1996, 428, 29.